Podcasts about naat

Pastor Naat shares her own journey of coming to Christ and living missionally in Thailand through simple story-telling and connecting. Rebecca, who has worked closely with Naat does the translating. 

Trichomonas vaginalis is increasingly recognized as an important pathogen with potentially great morbidity. Dr. Patricia Kissinger, a Tulane School of Public Health and Tropical Medicine Professor and national expert, discusses screening and testing for T. vaginalis with National STD Curriculum Podcast Editor Dr. Meena Ramchandani. View episode transcript at www.std.uw.edu.This podcast is dedicated to an STD [sexually transmitted disease] review for health care professionals who are interested in remaining up-to-date on the diagnosis, management, and prevention of STDs. Editor and host Dr. Meena Ramchandani is an Assistant Professor of Medicine at the University of Washington (UW) and Program Director of the UW Infectious Diseases Fellowship Program. 

Scopri la Bibbia un versetto per volta con semplici commenti dell'insegnante Egidio Annunziata.LETTURA DELLA SACRA BIBBIAGenesi 36 - https://www.bible.com/it/bible...1 Questa è la discendenza di Esaù, cioè Edom.2 Esaù prese le sue mogli tra le figlie dei Cananei: Ada, figlia di Elon, l'Ittita; Oolibama, figlia di Ana,3 figlia di Sibeon, l'Ivveo; e Basmat, figlia d'Ismaele, sorella di Nebaiot.4 Ada partorì Elifaz a Esaù.5 Basmat partorì Reuel; e Oolibama partorì Ieus, Ialam e Cora. Questi sono i figli di Esaù, che gli nacquero nel paese di Canaan.6 Esaù prese le sue mogli, i suoi figli, le sue figlie, tutte le persone della sua casa, le sue greggi, tutto il suo bestiame e tutti i beni che aveva messi insieme nel paese di Canaan, e se ne andò in un altro paese, lontano da Giacobbe suo fratello,7 poiché il loro bestiame era troppo numeroso perché essi potessero abitare insieme; il paese nel quale soggiornavano non era loro sufficiente a causa del loro bestiame.8 Così Esaù abitò sulla montagna di Seir. Esaù è Edom.9 Questa è la discendenza di Esaù, padre degli Edomiti, sulla montagna di Seir.10 Questi sono i nomi dei figli di Esaù: Elifaz, figlio di Ada, moglie di Esaù; Reuel, figlio di Basmat, moglie di Esaù.11 I figli di Elifaz furono: Teman, Omar, Sefo, Gatam e Chenaz.12 Timna era la concubina di Elifaz, figlio di Esaù; ella partorì Amalec a Elifaz. Questi furono i figli di Ada, moglie di Esaù.13 Questi furono i figli di Reuel: Naat e Zerac, Samma e Mizza. Questi furono i figli di Basmat, moglie di Esaù.14 Questi furono i figli di Oolibama, figlia di Ana, figlia di Sibeon, moglie di Esaù; ella partorì a Esaù: Ieus, Ialam e Cora.15 Questi sono i capi dei figli di Esaù: figli di Elifaz, primogenito di Esaù: il capo Teman, il capo Omar, il capo Sefo, il capo Chenaz,16 il capo Cora, il capo Gatam, il capo Amalec; questi sono i capi discesi da Elifaz, nel paese di Edom, e sono i figli di Ada.17 Questi sono i figli di Reuel, figlio di Esaù: il capo Naat, il capo Zerac, il capo Samma, il capo Mizza; questi sono i capi discesi da Reuel, nel paese di Edom. E sono i figli di Basmat, moglie di Esaù.18 E questi sono i figli di Oolibama, moglie di Esaù: il capo Ieus, il capo Ialam, il capo Cora; questi sono i capi discesi da Oolibama, figlia di Ana, moglie di Esaù.19 Questi sono i figli di Esaù, che è Edom, e questi sono i loro capi.20 Questi sono i figli di Seir, il Coreo, che abitavano il paese: Lotan, Sobal, Sibeon, Ana,21 Dison, Eser e Disan. Questi sono i capi dei Corei, figli di Seir, nel paese di Edom.22 I figli di Lotan furono: Cori ed Eman; e la sorella di Lotan fu Timna.23 Questi sono i figli di Sobal: Alvan, Manaat, Ebal, Sefo e Onam.24 Questi sono i figli di Sibeon: Aia e Ana. Questo è quell'Ana che trovò le acque calde nel deserto, mentre pascolava gli asini di suo padre Sibeon.25 Questi sono i figli di Ana: Dison e Oolibama, figlia di Ana.26 Questi sono i figli di Dison: Chemdan, Esban, Itran e Cheran.27 Questi sono i figli di Eser: Bilan, Zaavan e Acan.Episodio: Genesi 36Conduttore: Egidio AnnunziataLuogo: Nocera Inferiore, Salerno - ItalyEvento: Incontro domenicale della comunità Essere Un CristianoData: 27/08/2023Lingua: ItalianaProduzione: © Essere Un Cristiano 2023

Episode 162: Early-Onset Sepsis      Dr. Kooner explains how to diagnose early-onset sepsis by using clinical evaluation and clinical tools. Dr. Schlaerths describes the signs and symptoms of sepsis in neonates, and Dr. Arreaza adds comments about GBS bacteriuria.  Written by Lovedip Kooner, MD, editing Hector Arreaza, MD, and comments by Katherine Schlaerth, MD. Rio Bravo Family Medicine Residency Program.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction:Neonatal sepsis is defined as pathogenic bacterial growth from blood or cerebral spinal fluid culture within the first 28 days of life. Neonatal sepsis can be divided into two categories: early-onset sepsis (EOS) and late-onset.  EOS is neonatal sepsis within 72 hours or 7 days after birth, depending on the specialist. How common is early-onset sepsis (EOS)?According to the CDC, the infant mortality rate rose for the first time in 20 years in the USA. In the U.S., the incidence of EOS is 0.5 in 1,000 live births and carries a mortality rate of about 3%. What causes EOS?Most infections are due to ascending lower vaginal tract flora. Other causes include intra-amniotic infections and maternal hematogenous spread of systemic infections. Group B streptococcus (S. agalactiae) accounts for about 1/3 of the infectious organisms, followed by E. coli which accounts for about 1/4, and Viridans streptococci account for about 1/5 of infections. Cases of E. coli are seen more often with prolonged rupture of membranes and intrapartum antibiotic exposure. Other notable infections are Listeria monocytogenes, coagulase-negative staphylococci (CoNS), herpes simplex virus, and enteroviruses. The role of GBS.Approximately 30% of women have vaginal and rectal GBS colonization and 50% will transmit it to the newborn. Without maternal antibiotic treatment, 1-2% of those infants will develop EOS. The American College of Obstetricians and Gynecologists (ACOG) recommends universal culture-based screening for GBS at 36-37 weeks and 6 days regardless of mode of delivery. GBS bacteriuria: Treat it (symptomatic and asymptomatic) if >105 CFU/mL. Do not treat it in asymptomatic patients if GBS 18 hours, intrapartum fever, or GBS positive in previous pregnancy.Nucleic acid amplification test: NAAT in pregnancy is not recommended to determine colonization status. However, if NAAT is obtained in the intrapartum period, give IAP if positive. But, you must also give IAP if negative + mentioned risk factors (18h, Maternal fever >100.4F)What is considered adequate intrapartum antibiotic prophylaxis? Penicillin and ampicillin are the recommended antibiotics for prophylaxis. Cefazolin can be given if there is a penicillin-allergy with a low risk for anaphylaxis. Clindamycin and vancomycin are reserved for cases of maternal penicillin allergy. Specifically, clindamycin can be used only if GBS is known to be sensitive to clindamycin. Vancomycin must be used if GBS is resistant to clindamycin. Do not use erythromycin. You will Administered at least 4 hours before delivery.IAP is believed to reduce neonatal GBS disease by: (1) temporarily reducing maternal vaginal GBS colonization; (2) preventing colonization of the fetus or newborn's surfaces and mucous membranes; and (3) achieving antibiotic levels in the newborn's bloodstream sufficient to surpass the minimum inhibitory concentration (MIC) for eliminating group B streptococci.Diagnosis of EOS:Clinical presentation: Tachycardia, tachypnea, temperature instability, supplemental oxygen requirement, and lethargy. Hypoglycemia should not be considered a sign of EOS.Diagnosing early-onset sepsis is achieved through blood or cerebrospinal fluid (CSF) cultures. Not effective methods for diagnosing EOS include laboratory tests, such as a complete blood cell count or C-reactive protein (CRP), as well as surface cultures, gastric aspirate analysis, or urine culture.Most infants will generally show signs of EOS GBS infection within the initial 24 hours of birth, with approximately 85% exhibiting symptoms during this timeframe.Waiting for cultures and/or signs can delay lifesaving treatment.Management:According to the American Academy of Pediatrics (AAP), the management of term and late-term infants is undertaken via the clinical condition assessment, the categorical risk factor assessment, and the multivariate risk assessment. As a part of the 2015 AAP guidelines, the Categorical Risk Factor Assessment is more of an algorithmic approach based on the presence or absence of specific risk factor threshold values such as:Ill-appearing infant. Mother diagnosed with chorioamnionitis.Mother GBS positive with inadequate intrapartum prophylaxis.ROM >18 hours.Birth before 37 weeks of gestation.Antibiotics are not always needed, and they can even cause damage. Information taken from the American Academy of Pediatrics, “Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis,” published on December 1, 2018:(1) Any newborn infant who is ill-appearing or (2) when the mother has a clinical diagnosis of chorioamnionitis -> laboratory testing must be ordered, and empirical antibiotic therapy should be started.(3) A mother who is colonized with GBS and who received inadequate intrapartum antibiotic prophylaxis, with a duration of ROM being >18 hours or birth before 37 weeks' gestation -> laboratory testing should be ordered.(4) A mother who is colonized with GBS who received inadequate IAP but with no additional risk factors -> observation in the hospital for ≥48 hours.______________________________Conclusion: Now we conclude episode number 162, “Early-onset Sepsis Introduction.” Dr Kooner explained the role of GBS in the pathophysiology of EOS, Dr. Schlaerth discussed the importance of clinical evaluation and Dr. Arreaza explained that GBS screening in the third trimester is not needed when there is a GBS positive urine culture early in pregnancy. Don't miss part 2 of this discussion. By the way, we do not recommend using feces to prevent or treat sepsis, we just shared anecdotal information to end with a funny note.This week we thank Hector Arreaza, Lovedip Kooner, and Katherine Schlaerth. Audio editing by Adrianne Silva.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Neonatal Early-Onset Sepsis Calculator by Kaiser Permanente, available at: https://neonatalsepsiscalculator.kaiserpermanente.org/.Espinosa K, Brown SR. Neonatal Early-Onset Sepsis Calculator. Am Fam Physician. 2021;104(6):636-637.https://www.aafp.org/pubs/afp/issues/2021/1200/p636.html.Puopolo KM, Benitz WE, Zaoutis TE; COMMITTEE ON FETUS AND NEWBORN; COMMITTEE ON INFECTIOUS DISEASES. Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics. 2018 Dec;142(6):e20182894. doi: 10.1542/peds.2018-2894. PMID: 30455342. https://pubmed.ncbi.nlm.nih.gov/30455342/.Briggs-Steinberg C, Roth P. Early-Onset Sepsis in Newborns. Pediatr Rev. 2023 Jan 1;44(1):14-22. doi: 10.1542/pir.2020-001164. PMID: 36587021. https://pubmed.ncbi.nlm.nih.gov/36587021/.Flannery DD, Puopolo KM. Neonatal Early-Onset Sepsis. Neoreviews. 2022 Nov 1;23(11):756-770. doi: 10.1542/neo.23-10-e756. PMID: 36316253. https://pubmed.ncbi.nlm.nih.gov/36316253/.Polin RA; Committee on Fetus and Newborn. Management of neonates with suspected or proven early-onset bacterial sepsis. Pediatrics. 2012 May;129(5):1006-15. doi: 10.1542/peds.2012-0541. Epub 2012 Apr 30. PMID: 22547779. https://pubmed.ncbi.nlm.nih.gov/22547779/.Royalty-free music used for this episode: Good Vibes_Adventure Time by Simon Pettersson, downloaded on July 20, 2023, from https://www.videvo.net/  

In this episode, Raymund Razonable, MD, discusses cytomegalovirus (CMV) management strategies beyond primary prophylaxis in solid organ transplantation recipients including:CMV treatment goals CMV treatment and monitoring recommendationsRole of secondary prophylaxisUse of CMV cell–mediated immunity (CMI) monitoring for CMV relapse riskUse of CMV CMI for secondary prophylaxis Proposed use of CMV CMI monitoring for secondary prophylaxisIncidence and outcomes with antiviral resistance Risk factors for CMV resistanceWhen to suspect antiviral resistance Testing for antiviral resistance using genotypic assaysOutcomes in patients with ganciclovir-resistant vs ganciclovir-susceptible virusTreatment recommendations for resistant/refractory CMVEfficacy and safety of maribavir vs investigator-assigned therapy for resistant/refractory CMV infections from the phase III SOLTICE studyTreatment algorithm for resistant/refractory CMV Adjunctive, investigational, and off-label treatment options for resistant/refractory CMV Faculty:Raymund Razonable, MDProfessor of MedicineProgram Director, Infectious Diseases FellowshipVice Chair, Division of Infectious DiseasesMayo ClinicRochester, Minnesota Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.Follow along with a downloadable slideset at: https://bit.ly/476v2wILink to full program: https://bit.ly/47lNK2K

On episode #37 of the Infectious Disease Puscast, Daniel reviews the infectious disease literature for the weeks of 8/31 – 9/13/23. Host: Daniel Griffin and Sara Dong Click arrow to play Download Puscast 037 (22 MB .mp3, 31 min) Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of Puscast! Links for this episode Association between varicella zoster virus and dementia (NS) Safety, efficacy, and immunogenicity of V160 vaccine in cytomegalovirus-seronegative women (The Lancet) Microorganisms detected in intussusception cases and controls in children (OFID) Clinician testing and treatment thresholds for management of UTIs (OFID) Clinical outcomes and management of NAAT-positive/toxin-negative Clostridioides difficile infection (CID) Associations of standard care, intrathecal antibiotics, and antibiotic impregnated catheters with cerebrospinal fluid shunt infection (JPIDS) Advances in asynchronous telemedicine call for increased antibiotic surveillance (CID) Two artificial tears outbreak-associated cases of extensively drug-resistant Pseudomonas aeruginosa detected through whole genome surveillance (JID) Pre-XDR congenital TB in an extremely premature baby (CID) Emerging Roles of (1→3)-β-D-glucan in cerebrospinal fluid for detection and therapeutic monitoring of fungal diseases (CID) Outbreak of locally acquired mosquito-transmitted malaria (CDC) Complexity of infectious diseases compared to other cognitive medical subspecialties (OFID) Risk of opportunistic infections associated with long-term glucocorticoid therapies in adults (CID) Music is by Ronald Jenkees

This Podcast features Peter Ngo'la Owiti, who is on the Executive Committee Board of Stop TB Partnership, and also represents communities on Medicines Patent Pool. He is also the Executive Director of the Wote Youth Development Projects, Kenya. Listen to his insights on why stock-outs of medicines for drug-sensitive TB, essential needs which are required to refer patients, or of cartridges to run nucleic acid amplification tests (NAAT) molecular diagnostics such as Gene Xpert are not acceptable.Listen to this podcast on Apple Podcasts, Amazon Music, Google Podcasts, Spotify, Stitcher, TuneIn, aCast, Podtail, BluBrry, Himalaya, ListenNotes, American Podcasts, CastBox FM, Ivy FM, Player FM, and other podcast streaming platforms.ThanksCNS team

Qira'ah & Naat Jalsah | 9 June 2023 by Ubeidullah Bulbulia

Zahid Manzoor Bhat, a resident of Gutroo village in Aripal Tehsil of Tral, said that listening to Sufi saints since his childhood inspired him to pen down hundreds of poems, most of them in Kashmiri. “Sufi poets like Rajab Hamid, Rasool Mir, Shamas Fakeer, Rahim Sopore inspired me since my childhood.Once a Teacher Namely Abdul Rashid saw some couplets on my notebook While checking when i was in class 8th then he said you will become a poet”. And by listening and reading the writings of sufi poets, I have written over 500 poems. Most of my poems are Naat and Hamud,” Bhat said. After a lot of struggle Bhat turned his poetry collection into a book which he wasn't able to do due to financial issues. “My father died when I was just 3 years old and we got some help from a Yateem trust and after completing my Bachelors, I started to work as a private school teacher where I am getting meager salary to take care of my family which comprises of the mother, grandmother and the younger brother,” he said. “I wanted to publish my book but I am hardly fulfilling the needs of the family, but now some friends helped to publish the first book, titled “Hayaatuk-Aab ”. Bhat said most of his work is yet to be published while besides promoting Sufism, the main motive behind writing the poems in Kashmiri is to promote the mother tongue. “In my poems, I have touched social issues as well. We are losing our culture which is our identity and are only propagating western culture,” he said. “Our valley is full of talent, but the financial issues and lack of platform are becoming an obstacle for thousands of youth to get their dreams fulfilled,” he said.

Alvida Alvida Mahe ramadan - Naat

In 2018, the ACOG recommended immediate induction of labor/delivery for patients with PPROM, who had sure gestational dating, and were at 34 weeks and 0 days or more. This was in order to reduce the risk of neonatal sepsis. This changed, however, in 2020 with ACOG Practice Bulletin 217 which discussed expected management for PPROM in the late preterm interval. Nonetheless, as is our tagline for this podcast, “medicine moves fast”. In February 2023, a current commentary was published in BJOG adding a cautionary note to the option of expected management in the late preterm interval. In this episode, we will review the acog guidelines, review GBS culture versus NAAT, and summarize this current commentary from BJOG. What is the one clinical factor that should be considered in planning for expected management with PPROM in the late preterm interval? We will explain it in this episode.

Join us for an extended discussion with CTO and founder of North American Access Technologies Julius Neudorfer about the history of liquid cooling, and where he sees the market developing in the future.

Vandaag het gesprek met Jan van der Spoel. Jan werkt meer dan 30 jaar in corporate communicatie als Creative Director en Concept Designer en heeft geleerd dat alles wat te maken heeft met leiderschap en hoe we samenwerken, op de een of andere manier, terug te voeren is op vertrouwen. Hij heeft zich verdiept in bestaande wetenschappelijke modellen en concepten over vertrouwen en heeft het Grip on Trust Model ontworpen dat je helpt om de juiste vragen te stellen en de dynamiek van vertrouwen in de meeste relaties te begrijpen. Jan is gedreven om bij te dragen aan betere relaties en een gelukkiger leven. Dit gesprek nam ik op met co-host Simone Beerepoot. Laten we beginnen… In gesprek met Jan leerde ik: Vertrouwen is de smeerolie van de maatschappij Als er geen vertrouwen is dan heb je regels, afspraken en controleurs nodig. Karakter, intentie, respect en eerlijkheid bepalen het vertrouwen in de ander. Als iemand in een machtspositie terecht komt dan veranderd zijn gedrag. Zijn empathisch vermogen en moreel kompas veranderd. Als we moe worden of alcohol op hebben dan werkt ons brein op instinct of intuïtie. Als we zo doorgaan, gaan we naar een samenleving zonder vertrouwen. Het ambacht van vertrouwen - de huisstijl en communicatie - is overgenomen door likes, en clicks en manipulatie. Naat het bruto nationaal product (bnp) wil Jan het bruto nationaal vertrouwen (bnv) ontwikkelen. Wat doet het met het vertrouwen van de stakeholders. Vertrouwen is onzichtbaar en veranderd voortdurend. Met het model van Jan kun je het telkens zichtbaar maken. (Universal principles of Trust) Patronen van vertrouwen bewust en meetbaar maken in de maatschappij. Vier verschillende fases in de loopbaan: first time managers, mid career managers, CEO's en vrouwen. 60% van de first time managers valt uit binnen 18 maanden. Vrouwen verlaten nu meer dan ooit de topfunctie. Voor iedere vrouw die wordt aangenomen, verlaten er twee diezelfde rol. Meer over Jan van der Spoel: https://www.linkedin.com/in/janvanderspoel/ Gripontrust.com Andere bronnen: Universal Principles of Trust - Jan van der Spoel (PDF) Dacher Keltner - The Power Paradox Ricardo Semler - Het weekend van zeven dagen en Semco stijl. Co-host Simone Beerepoot: https://www.linkedin.com/in/simone-beerepoot/ nomadsofchange.com Video van het gesprek met Jan van der Spoel https://youtu.be/y3Y8deBlvWU Kijk hier https://youtu.be/y3Y8deBlvWU

Emotional heart touching naat || Mere Aaqa. --- Send in a voice message: https://anchor.fm/the-knowledge3/message

Nach der erzwungenen Landung auf Naat, der gescheiterten Flucht und dem Intermezzo mit dem Arkoniden Sergh, starte ich in meinem Perry Rhodan Reread Podcast, nach Arkon I. Dort haben Perry und seine Freunde die erste Begegnung mit dem arkonidischen Imperator, der zur Marionette des Robotregenten verkommen ist. Was die Reise bringt und welche Pläne die Menschen in den Blick nehmen, hört ihr in diesem Podcast.

Naat CHALO DAYAAReNABI KI JANIB چلو دیارِ نبی کی جانب

142 Saal purani Naat-E-Paak Raat Ke Safar Mein RJ Adhury Hayat ke sath

142 Saal purani naat-E-Paak ek aise dilkash aur Ruhani Awaaz me jisko sunkar dil khush ho jaye aur rooh taza ho jaye RJ Adhury Hayat ke sath sunai

Abid Rasheed is quite popular in Urdu literary circles in North America. He is an engineer by profession who lives in Chicago. He is the founder of Sukhanwar Chicago & Hareem-e-Naat. His published work of poetry is titled “Dhanak”Abdul Raoof Siddiquiemail: raoof3@yahoo.com Instagram @urdu.ghazal Visit our website: www.mstn.in#urdupoetry #abidrasheed

Engineer Muhammad Ali Mirza --- Send in a voice message: https://anchor.fm/muhammad-imran984/message

Saira Mehraj & Asma Jan are two young Naat Singers ( Naat Khawan ) born and brought up in a small village in Pulwama District. At a young age, they performed on many stages including Television shows and radio. Tune-in to Podcast !

Episode 89: Gonorrhea Basics. Written by Robert BensacenezRobert, Dr. Schlaerth, and Dr. Arreaza discuss the basics of gonorrhea, including presentation, treatment, and even a potential gonococcal vaccine.Introduction: Gonorrhea is commonly known as “the clap” or “the drip”. This ancient disease, described as “the perilous infirmity of burning” in a book called The History of Prostitution, has been treated with many remedies throughout history, including mercury, sulfur, silver, multiple plants, and even gold. Today we will discuss the clinical features, diagnosis, and current therapy of gonorrhea. By the way, did you know that gonorrhea in Spanish is used as an insult in Colombia? Well, now you know it. Definition: Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae (common name gonococcus), which is a gram-negative, intracellular, aerobic, diplococci. This disease leads to genitourinary tract infections such as urethritis, cervicitis, pelvic inflammatory disease (PID), and epididymitis. This is Rio Bravo qWeek, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California. Our program is affiliated with UCLA, and it's sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. ___________________________Gonorrhea. Written by Robert Besancenez, MS4, Ross University School of Medicine. Moderated and edited by Hector Arreaza, MD. Discussion participation by Katherine Schlaerth, MD. Epidemiology: The disease primarily affects individuals between 15–24 years of age (half of the STI patients in the US). CDC estimates that approximately 1.6 million new gonococcal infections occurred in 2018. Incidence rates are highest among African Americans, American Indians, and Hispanic populations.Transmission is sexual (oral, genital, or anal) or perinatal (causing gonococcal conjunctivitis in neonates). Risk factors include unsafe sexual behaviors (lack of barrier protection, multiple partners, men who have sex with men (MSM), and asplenia, complement deficiencies. Individuals with low socioeconomic status are at the highest risk: poor access to medical treatment and screening, poor education, substance use, and sex work. Presentation: The incubation period is ~ 2–7 days, and sometimes patients do not develop any symptoms. Urogenital infection: Gonorrhea is commonly asymptomatic, especially in women, which increases the chance of further spreading and complications. When symptoms are present, typical symptoms include purulent vaginal or urethral discharge (purulent, yellow-green, possibly blood-tinged). Discharge is less common in female patients. Urinary symptoms include dysuria, urinary frequency, and urgency. Male: - Typical presentation is urethritis. - Penile shaft edema without other signs of inflammation.- Epididymitis: unilateral scrotal fullness sensation, scrotal swelling, redness, tenderness, relief of pain with elevation of scrotum —Prehn Sign— and positive cremasteric reflex.- Robert: Prostatitis: fever, chills, general malaise, pelvic or perineal pain, cloudy urine, prostate tenderness (examine prostate gently). Female: - Cervicitis: Friable cervix and discharge (purulent, yellow, malodorous), - PID: pelvic or lower abdominal pain, dyspareunia, fever, cervical discharge, cervical motion tenderness but also uterine or adnexal tenderness, abnormal intermenstrual bleeding. PID can be subclinical and diagnosed retroactively when tubal occlusion is discovered as part of a workup for infertility. PID can cause Fitz-Hugh-Curtis syndrome (perihepatitis with RUQ pain).- Bartholinitis presents with introitus pain, edema, and discharge from the labia. - Vulvovaginitis may occur but is rare (due to the tissue preference of gonococci)Extragenital infection: Proctitis: Rectal purulent discharge, possible anorectal bleeding and pain, rectal mucosa inflammation, or rectal abscess (less common).Pharyngitis: sore throat, pharyngeal exudate, cervical lymphadenitis.  Disseminated gonococcal infection (DGI): Triad of arthritis, pustular skin lesions, and tenosynovitis.  As mentioned in Episode 46, on December 23, 2020, the California Department of Public Health (CDPH) sent a “Dear Colleague” letter to warn the medical community about the increased cases of DGI in California and Michigan. Increased cases may be caused by decreased STD testing and treatment because of the COVID-19 pandemic, and not necessarily because of a more virulent strain of gonorrhea. Later, treatment of gonorrhea was updated because of resistance.  Epidemiology: ∼ 2% of cases. Most common in individuals younger than 40 years old, the female to male ratio is 4:1. A history of recent symptomatic genital infection is uncommon. Asymptomatic infections increase the risk of dissemination due to delayed diagnosis and treatment. Clinical features: Two distinct clinical presentations are possible. Arthritis-dermatitis syndrome:Polyarthralgias: migratory, asymmetric arthritis that may become purulent.Tenosynovitis: simultaneous inflammation of several tendons (e.g. fingers, toes, wrist, ankle).Dermatitis: vesicular, pustular, or maculopapular lesions, possibly with a necrotic or hemorrhagic center.  Most commonly distributed on the trunk, extremities (sometimes involving the palms and soles). Typically, < 10 lesions with a transient course (subside in 3–4 days). Additional manifestations: fever and chills (especially in the acute phase). Purulent gonococcal arthritis: Abrupt inflammation in up to 4 joints (commonly knees, ankles, and wrists). No skin manifestations, rarely tenosynovitis. Genitourinary manifestations in only 25% of affected individuals. Not to be confused with reactive arthritis.  Health care providers living in California: Order Nucleic acid amplification test (NAAT) and culture specimens from urogenital, extragenital mucosal sites (e.g., pharyngeal and rectal), and from disseminated sites (e.g., skin, synovial fluid, blood, and cerebrospinal fluid) before initiating empiric antimicrobial treatment for patients with suspected DGI. Report within 24 hours of diagnosis to the California Department of Public Health. Complications of DGI: sepsis with endocarditis, meningitis, osteomyelitis, or pneumonia. Diagnosis of gonorrhea: The test of choice is Nucleic acid amplification testing (NAAT) of first-catch urine or swabs of urethra, endocervix and pharynx, and synovial fluid in disseminated infection. Other possible tests: gram stains and bacterial cultures (Thayer-Martin agar, useful for antibiotic resistance, results may take 48 hours, sensitivity is lower than NAAT.)Synovial fluid analysis: Appearance of fluid can be clear or cloudy (purulent), high Leukocyte count (up to 50,000 cells/mm3): especially segmented neutrophils, gram stain positive in < 25% of cases. Treatment: Ceftriaxone and doxycycline for uncomplicated cases, but may require different approaches in case of allergies or intolerance to these antibiotics, or in severe cases.  Uncomplicated gonorrhea (affecting cervix, urethra, rectum, pharynx)First-line treatment: single-dose ceftriaxone 500 mg IM (1 G for patients >150 Kg) PLUS doxycycline 100 mg PO twice a day for 7 days If a chlamydial infection has not been excluded.During pregnancy: Ceftriaxone PLUS single-dose azithromycin 1 gram PO(doxy is contraindicated – teratogen) Complicated gonorrhea (salpingitis, adnexitis, PID/ epididymitis, orchitis)Single-dose ceftriaxone IM PLUS doxycycline PO for 10–14 days  (women may require additional administration of Metronidazole PO for 14 days).  DGICeftriaxone IV every 24 hours for 7 days In case Chlamydia infection has not been ruled out: PLUS doxycycline PO twice a day for 7 daysDrainage of purulent joint(s) Sequelae: Without treatment, a prolonged infection may lead to complications, such as hymenal and tubal synechiae that lead to infertility in women. Prevention:-Screening for gonorrhea (USPSTF recommendations, September 2021, Grade B): Annual NAAT screening of gonorrhea AND chlamydia for sexually active women ≤ 24 years (including pregnant persons) or > 25 years with risk factors (e.g. new or multiple sex partners, sex partner with an STI, etc.). Evaluate for other STIs if positive (e.g. chlamydia, syphilis, and HIV).  There is insufficient evidence to recommend for or against screening gonorrhea in asymptomatic males (Grade I).In all patients: Evaluate and treat the patient's sexual partners from the past 60 days. Provide expedited partner therapy if the timely evaluation of sexual partners is not feasible. Single-dose cefixime PO (if chlamydia has been excluded in the patient) OR Single-dose cefixime PO PLUS doxycycline PO for 7 days. Sexual partners must be treated simultaneously to avoid reinfections. A possible gonococcal vaccine: A gonococcal vaccine is theoretically possible, let's remember that the meningococcal vaccine exists. Meningococcus is closely related to gonococcus. A study published in 2017 showed that MeNZB® (a vaccine used in New Zealand until 2011 to fight against a meningitis epidemic) provided partial protection against gonorrhea. Food for thought for you guys. Conclusion: Let's remember to screen asymptomatic women for gonorrhea, identify symptomatic patients and start treatment promptly, and prevent serious complications, and more importantly, let's promote safe sex practices to prevent this disease.Now we conclude our episode number 89 “Gonorrhea Basics”. Gonorrhea affects mainly the urogenital area, but it can spread to the pharynx, rectum, skin, and even joints. When you see septic arthritis in patients with high risk for gonorrhea, suspect disseminated gonococcal infection and start treatment promptly. Even without trying, every night you go to bed being a little wiser.Thanks for listening to Rio Bravo qWeek. If you have any feedback about this podcast, contact us by email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. This podcast was created for educational purposes only. Visit your primary care physician for additional medical advice. This week we thank Hector Arreaza, Robert Besancenez, and Katherine Schlaerth. Audio edition: Suraj Amrutia. See you next week! _____________________References:Seña, Arlene C, MD, MPH; and Myron S Cohen, MD.  Treatment of uncomplicated Neisseria gonorrhoeae infections, UpToDate, updated on Jan 27, 2022. Accessed on April 5, 2022. https://www.uptodate.com/contents/treatment-of-uncomplicated-neisseria-gonorrhoeae-infections Ghanem, Khalil G, MD, PhD. Clinical manifestations and diagnosis of Neisseria gonorrhoeae infection in adults and adolescents, UpToDate, updated on Sep 17, 2021, accessed on April 5, 2022. https://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-neisseria-gonorrhoeae-infection-in-adults-and-adolescents Klausner, Jeffrey D, MD, MPH. Disseminated gonococcal infection, UpToDate, updated on March 3, 2022. Accessed on April 5, 2022. https://www.uptodate.com/contents/disseminated-gonococcal-infection Petousis-Harris H, Paynter J, Morgan J, et al. Effectiveness of a group B OMV meningococcal vaccine on gonorrhea in New Zealand – a case control study. Abstract presented at: 20th International Pathogenic Neisseria Conference. Manchester, UK; 2016. 

Hamd, naat, nasheed, television, radio, and street soundscapes of Ramadan.

2/11/2022 Additional resources OHA: Find a COVID-19 vaccine OHA: COVID-19 vaccine information for parents, guardians and people under 18 OHA: COVID-19 vaccine boosters and third doses OHA: COVID-19 testing CDC: COVID-19 Testing: What You Need to Know CDC: COVID-19 Self-Testing Medline.gov – What are PCR tests? Federal Trade Commission: Don't assume every COVID-19 testing site is legit Oregon Department of Justice: COVID-19 Sales, Scams and Fraud U.S. Department of Health and Human Services: COVID-19 Scams OHA Facebook  Safe+Strong website Ask a Black Doctor on The Numberz REACH web page and REACH Facebook Reminders about health, safety and cleaning guidance Q1: What kind of COVID-19 tests are out there at the moment? COVID-19 tests can detect either SARS-CoV-2, the virus that causes COVID-19, or antibodies that your body makes after getting COVID-19 or after getting vaccinated. Tests for SARS-CoV-2 tell you if you have an infection at the time of the test. This type of test is called a “viral” test because it looks for viral infection. Antigen or Nucleic Acid Amplification Tests (NAATs) are viral tests.  Tests for antibodies may tell you if you have had a past infection with the virus that causes COVID-19. Your body creates antibodies after getting infected with SARS-CoV-2 or after getting vaccinated against COVID-19. These tests are called “antibody” or “serology” tests.  The CDC does not currently recommend antibody testing to find out if you have COVID-19. Only viral tests are recommended to detect current COVID-19 infection. Q2: Is it possible to get a false positive on a viral test? NAATs, or molecular tests, are considered the most accurate form of COVID-19 testing because they detect genetic material from the virus that causes COVID-19. Polymerase chain reaction (PCR) tests are a type of NAAT. These tests are processed by certified laboratories, with most results available in 2 to 5 business days. Unlike many other tests, PCR tests can detect the virus in the earliest stages of infection. Other tests may miss early signs of disease because there aren't enough viruses in the sample, or your body hasn't had enough time to develop an antibody response. This means the test can detect the virus even before you show symptoms of COVID-19. Antigen testing is faster, but not as accurate. It detects proteins from the virus that causes COVID-19. This means the test is best done when you are showing symptoms of COVID-19 or have a lot of virus in your system. False negatives can happen if your body doesn't have enough of the virus for an antigen test to detect.  This is why the Centers for Disease Control and Prevention (CDC) considers NAATs, such as PCR tests, the gold standard for COVID-19 testing.  The CDC also recommends getting a NAAT if an antigen test provides negative results, but you have symptoms of COVID-19. But overall, positive viral tests are right more than 95% of the time. Q3: What are some of the aspects to consider in self testing for COVID-19? COVID-19 self-tests at home are one of many risk-reduction measures, along with vaccination, masking, and physical distancing, that protect you and others by reducing the chances of spreading SARS-CoV-2, the virus that causes COVID-19.  A positive self-test result means that the test detected the virus, and you must isolate so as to reduce the risk of spreading disease to someone else.  A negative self-test result means that the test did not detect the virus and you may not have an infection, but it does not entirely rule out infection. Repeating the test within a few days, with at least 24 hours between tests, will increase the confidence that you are not infected. The best time to test is 3 to 8 following an exposure and/or when you have symptoms. Q4: What are some things to look out for if I think I may be giving my information to a fake COVID testing site? Some warning signs that you can look out for are things such as: A provider asking about your nationality or immigration status. A site asking for your Social Security number. No notice of privacy practices provided, or no explanation for how your personal data will be used. A provider demanding to see your passport or driver's license when you have other documents that show your insurance status. Employees at the site who are not wearing full protective gear. Misspellings or unusual names in the URL for the website where the testing provider required you to sign up online. An unsolicited call or text from the testing site. If you receive one, do not provide any personal information until you have confirmed that source of the call or text is legitimate. Q5: Where can I go to find legitimate COVID testing sites in my local area? If you are looking for information on where to get tested for COVID-19, you can contact your primary health care provider or visit Oregon Health Authority's COVID testing web page at healthoregon.org/covid19testing. Q6: At what point should I take an at-home COVID test? People with symptoms can take a rapid antigen test immediately, experts said, but those who have had a known exposure to the virus should wait three to five days before doing so. Testing too soon, before the virus has had a chance to replicate, increases the odds of a false negative. Q7: What has happened if self-tested results show “Invalid” or “Error”? This means your specimen may not have been collected correctly, or the test may have malfunctioned. Invalid test results are rare but can occur. If the self-test shows an invalid result or a test error, the test did not work properly. If this happens, refer to the instructions for use in the package insert and contact the manufacturer for assistance. When in doubt about the whole process then seek professional help. Local vaccine events Date Time Location AddressSaturday, Feb. 12 | 11 a.m. to 4 p.m. | Rosewood Initiative | 16126 SE Stark StPortland, OR Tuesday, Feb. 15 | 2 to 8 p.m. | Lloyd Center | 1260 Lloyd CenterPortland, OR Thursday, Feb. 17 | 8 a.m. to 2 p.m. | Lloyd Center | 1260 Lloyd CenterPortland, OR You can find more vaccine events at multco.us/vaccineclinics. Document accessibility: For individuals with disabilities or individuals who speak a language other than English, OHA can provide information in alternate formats such as translations, large print, or braille. Contact the Health Information Center at 1-971-673-2411, 711 TTY or COVID19.LanguageAccess@dhsoha.state.or.us.

Dar-E-Nabi pe// Beautiful naat // 8D. --- Send in a voice message: https://anchor.fm/the-knowledge3/message

A very unique naat by Imam Ahmed Raza Alahir Rehma, In this Naat lips will not meet each other. Naat: Sayyade Kaunain Recited by: Qari Rizwan Khan Written by: Imam Ahmed Raza

Naat;M. Fethullah Gülen

Islamic Naat Sharif

Hep Seni Düşünmek

Ufkumda tüllenen Senin kemâlindir,Hayranın olup yandığım cemâlindir;Hüsûf peşinde hep bir sürü yarasa,Bu da benim gönlümdeki melâlimdir…Âh âh ediyorum kalıyor havada;Hep uzayıp gidiyor bir leyl-i yeldâ;Küsûf bitsin, güneş çıksın budur sevdam,Başka bir arzum olmadı bu dünyada…Hayalimde her zaman bir nurlu şafak,Tulû'un sadık habercisi ki ap-ak;Sızlanıp duruyorum, bitsin bu çile,Visâle dönsün şu kaç asırlık firak…Yine o hülyalara daldım bu gece,Mırıldanıp durdum O'nu hece hece;Zaten o sevdayla yatıp kalkıyorum,Her gün gönlü sarıyor daha derince…Bize bizden yakın hep yanımızdasın,Tende değil, gönül ve canımızdasın;Unutmamaya and içen gönülleriz,Kadrince olmasa da aşımızdasın…Muhammed Fethullah Gülen

Sun şerbet-i la'lini ki sermestin olayım,Girmesin sevda-yı ağyâr asla bu gönlüme;Ebedü'l-âbâd meftun-i cemâlin kalayım,Gölge etmesin kimse Sen gibi emelime…Çok kez elemle geçti bugüne dek baharım,Fark etmeden belki de dünyadan umdum vefa;Karardı o Mah-ı tâbâna rağmen neharım,Vefa umduklarımdan çektim bir hayli cefa…Sencileyin günler geçti besten yarım kaldı,Kapıldık akıntıya ki, yok limanı onun;Kapılar kilitli, anahtar ağyâr elinde,Mırıldanmaya durdu ye'is: “Bu senin sonun!..”Ey Nebî, ancak Seninle yeşerir bu bağlar,Döner iç içe hâristanlar bir gülistana;O güne dek hep gönüller boş günlere ağlar,Hazanlarla geçen bahara baharistana…Gül açar, bülbüller öter Sen dönüp gelince,Yaşarız hayatımızı Seninle derince;Şafakları şafaklar takip eder sâyende,Tüllenir güzellikler gül cemalin görünce…

Kanayan gönül yarası �irkatinden Senin,Bu derin yaranın dermanı da yine Sensin;Süzülen göz, dökülen yaş hepsi sevdandandır,Teveccüh ediver ki bütün ağrılar dinsin.Nurlu bakışına garip gönlüm bir hanedir,Şayet mamur etmezsen orası viranedir;Mahrum etme gönlümü bakışından dildârım,Kılmazsan şayet nazar, orası demhânedir…Bekleyip duruyorum sürprizden geliverse,Ü�leyiversin sûruna İsra�il isterse;Umurumda değil kıyametlerin kopması,Kanatlanır ve uçarım O “Ben geldim!” dese…Senelerce O'nu anmış kalbden ağlamış,Duyanların duyduğuna imrenmiş ve yanmış;Boşa akmadı inancım tamdır gözyaşlarım,Yoktur kapısına yönelen hiçbir aldanmış…Zulmetler içinde O bir gündüz güneşidir,Pür-envâr o Cennet günlerinin bir eşidir;İçten geçenleri itiraf edemem asla!..Bu bir Leylâ tutkusu ve bir Ferhat işidir…Fethullah Gülen Hocaefendi

Ey vefâlı Can, ey Canlara Cânân!..Bir vîrâneyiz Sen gideli inan!..Gel hasretlerimizi dindir ey Yâr!..Çevremiz buz kitlesi gibi ağyar.Sensiz bu hayat bize azap oldu,Her yanda şeytan otağı kuruldu;Lütfedip gel, canımızı verelim,Sunacağın iksirle dirilelim…Açılsın her yanda güller, laleler,Raksa dursun kudûmuna sümbüller;Doğ ruhlarımıza, son ümit Sensin,Yıllarca beklenmiştin, beklenensin…Gözlerden süzülenler sele döndü,Yoldakilerde ümit mumu söndü;Bendenin bağrında da bir yangın var,Sen teşrif edersen gelecek bahar…

Müjdeler olsun bizlere ki Sen varsın,Dîl-i pejmürdeye sebeb-i emânsın;Yolunda hep ölüp ölüp dirileyim,Sen benim ışığı kısılmaz şem'amsın…Gözlerin pür-nûr, bakışın ömür Senin,U

Ey sâki lütfet sun aşk şarabını,Ansızın vakt-i merhûn elden gider;Sil gönülden mâsivâ serabını!..Silinir aşk-ı lika dilden giderVur iştiyak tamburunu her gece!..İnlesin arz u sema o nağmeyle;Dillendirsin ruh onu hece hece,Semâa kalksın dil o velveleyle…Olsun o Hak nuruna bir pervane,Şakısın dil-dudak sevda yolunda;Bulsun bulacağını bu divane,“Sen, Sen!..” duyulsun sağında solunda.

Sensiz geçiyor yıllar ey Sevgili nerdesin?!.Uzak kaldık biz Senden, Sense hep kalblerdesin;Bir gülsün, bir bülbülsün, hiç dinmeyen nağmen var,Yaşıyorsun her çağda ve her an dillerdesin…Hayaline bend oldu bendegân gönülleri,Seni yâd ediyor her an onların dilleri;Dünya sevdalıları dünya deyip dursunlar,Sensin aşk erlerinin biricik emelleri…Bizler birer bendegân, Sen ise bir sultansın,Dudağının şerbetiyle dertlere dermansın;Senin nur iklimin âleme dâru'l-emândır,Sen bütün kapı kullarına cansın, canansın…

Gözlerimi Ceyhun EtGözlerimi ceyhun et, sinede ızdırap var,Güfte olsun gözyaşı, bestesi iniltiler;Sevgimi çalmak ister hain bakışlı ağyar,Ben söz geçiremiyorum, her şey Seni dinler.Kararmasın gönlüm, nezdinden bir nur saçıver!Düştüm ise uzak, maiyyetine çekiver!“Garîbem, bîkesem ve nâtüvânem” el-emân!Bir sürü yırtığımla huzurdayım dikiver!..

O zaman nurdan bir hâlen vardı hepsi de yâr,Hele o Ebû Bekir, Ömer, Osman ve Haydar!..İç içe yaşanıyordu adeta nevbahar,Bu garip gönlüm şimdi hep o günleri arar.

Binlerce yıl geçse de ben O'nu unutamam,Olmasa da alakam kametine göre tam;Gönülden sevdim O'nu seveceğim bilerek,Dilerim ömrüm o sevgi ile bulsun hitam…Demedim hiç: Sen bu çetin yolda gidemezsin,Hep pür-vefa aşkın dediğini edemezsin;“Sevda, sevda!..” demişiz Mecnun u Ferhat gibi,Aldırmadık diyene: “Bu dağı delemezsin…”

Duyurdun yine kendini bir gece,Keşke duyabilsem Seni her gece!..Gömülsem her dem irfan deryasına,Olsa o evkât benimçün pîr gece…Duysam ruhumda öteler sesini,Duyanlar gibi melek nefesini;Kâse-i aşkının meyine kansam,Kırsam nefsin yalancı kâsesini…

Sen çekip gittin büküldü boynumuz,Sarpa sardı yürünen düz yolumuz;Hedefte tepeleri aşmak vardı,Kırıldı kanadımız hem kolumuz…Yetiş ey Dost, bendenin imdadına!..Merhamet buyur âh u feryâdına!..Yolsuzlara yol âdâbını öğret!..Uyanıversinler Hak muradına…

Aşkın bir alev gibi düşsün sineme,Durmadan her an Seni ansın bu gönlüm;Yükselsin ruhumda aşkınla inleme,Nâr-ı iştiyakınla yansın bu gönlüm…Sen yok isen bahar gelmiş neyleyeyim,Sensiz geçen her bahar hazandır bana;Teşrifindir gönlümüze tek dileğim,Hasretimiz dönüştü ah u efgana…Yaz-bahar hayal bu yalancı dünyada,Aldatıyor hevâîleşmiş ruhları;Yaşamak güzeldir, olursa kapında,Bu tür hayat dindirir ah u vâhları…

Vuslat arzusuyla ömür hep âh ile geçti,Olmasa da liyakat, O bendesini seçti;Yer yer belki ruhum hayatın zehrini içti,Bundan, dedim, hayatımın şerefi ve mecdi…Şen günler hep neş'eyle benim yüzüme baktı,Bir inşirah olup gönlümün içine aktı;Bazen âteş-i suzân gibi bendeyi yaktı,Kedere gerek yok âşığın yanması haktı.Asla hiç açılmadı Hak'la gönül arası,Şeker-şerbet sayıldı dildeki aşk yarası;Sevimlidir aşkın hem akı hem de karası,Anlamaz bu neş'eyi bulunan kalb yarası.

Hülyalarımda Seni her gördüğümde,Yok oluverir bütün ağyar içimde;Silinir gözümde şatafat-ı dünya,Kesse önümü en büyülü biçimde.Zira ben kalb mihmanını bekliyorum,Her tıkırtıda “O geliyor!..” diyorum;Göz, kulak birliğiyle hemen her zaman,“Gelen O'dur!..” diyor ve seviniyorum…